Now you serine, now you don't
Trends in Pharmacological Sciences · 2025
DOI: 10.1016/j.tips.2025.10.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Pharmacological Sciences, 2025. Verfasst von Robert B Cameron und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Serine, Glioblastoma, Brain Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Cancer cells alter metabolic programs to support uncontrolled growth and proliferation. A new study from Scott and colleagues directly examined tumor metabolism in glioblastoma patients and discovered increased import of the amino acid serine. Excitingly, limiting serine uptake enhanced the effectiveness of chemoradiation in preclinical models of glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
- Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA. Electronic address: BFaubert@UChicago.edu.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- V Foundation
Zitieren
APA
Cameron, R. B., Hammond, N. G., & Faubert, B. (2025). Now you serine, now you don't. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2025.10.001
Vancouver
Cameron RB, Hammond NG, Faubert B. Now you serine, now you don't. Trends in Pharmacological Sciences. 2025. doi:10.1016/j.tips.2025.10.001
BibTeX
@article{Cameron2025,
author = {Cameron, Robert B and Hammond, Nia G and Faubert, Brandon},
title = {Now you serine, now you don't},
journal = {Trends in Pharmacological Sciences},
year = {2025},
doi = {10.1016/j.tips.2025.10.001}
}
EUVIMED